Stock 1612 VINCENT MEDICAL HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Vincent Medical Holdings Limited

Equities

1612

KYG9367D1025

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:27 2024-07-12 am EDT 		5-day change 1st Jan Change
0.405 HKD 0.00% Intraday chart for Vincent Medical Holdings Limited -3.57% +5.19%
May. 22 Vincent Medical Holdings Limited Approves Final Dividend for the Year Ended December 31, 2023 CI
Mar. 21 Vincent Medical Swings to Profit in 2023 as Revenue Jumps 14% MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 62% by 2026.
  • The company is in a robust financial situation considering its net cash and margin position.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • The company shows low valuation levels, with an enterprise value at 0.11 times its sales.
  • The company appears to be poorly valued given its net asset value.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Historically, the company has been releasing figures that are above expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
VINCENT MEDICAL HOLDINGS LIMITED Stock Vincent Medical Holdings Limited
+5.19% 33.89M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.31% 181B
C+
MEDTRONIC PLC Stock Medtronic plc
-5.38% 99.95B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.04% 66.21B
A
HOYA CORPORATION Stock Hoya Corporation
+16.45% 45.4B
B+
DEXCOM, INC. Stock DexCom, Inc.
-8.08% 45.36B
B-
CENCORA, INC. Stock Cencora, Inc.
+8.38% 43.84B
B-
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+12.06% 29.03B
B
TERUMO CORPORATION Stock Terumo Corporation
+17.98% 25.64B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.28% 23.53B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 1612 Stock
  4. Ratings Vincent Medical Holdings Limited